Routine antenatal screening and neonatal immunisation have helped England achieve the World Health Organisation elimination targets for hepatitis B mother to child transmission.
The latest meeting of the SMA Screening In-service evaluation Partnership Board heard that significant progress had been made with the planning of the newborn screening ISE for spinal muscular atrophy.
Profile of UK NSC test expert member Professor Bethany Shinkins.
Today we have published the UK NSC annual report, summarising the committee’s work and achievements during the year 1 April 2023 to 31 March 2024
The UK NSC is working to understand multi-cancer detection tests and their possible impact on screening through multiple strands of work.
An update from the third meeting of the spinal muscular atrophy screening in-service evaluation partnership board.
Two new dates have been announced for our popular screening masterclasses in autumn 2024.
The UK NSC’s 2024 annual call for new screening topics has opened, giving stakeholders the chance to propose potential new screening programmes, new technologies we have not previously reviewed, modifications to current screening programmes, or early updates to topics the committee has considered recently.
Greg Fell brings public health passion and expertise to key role on the UK NSC.
The evaluation of screening babies for severe combined immune deficiency in the NHS has come to an end and the results are being analysed.